- Home
- KZIA vs APDN Comparison
KZIA vs APDN Comparison
Compare KZIA & APDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KZIA
- APDN
- Stock Information
- Founded
- KZIA 1994
- APDN 1983
- Country
- KZIA Australia
- APDN United States
- Employees
- KZIA N/A
- APDN N/A
- Industry
- KZIA Biotechnology: Pharmaceutical Preparations
- APDN Other Consumer Services
- Sector
- KZIA Health Care
- APDN Consumer Discretionary
- Exchange
- KZIA Nasdaq
- APDN Nasdaq
- Market Cap
- KZIA 860.8K
- APDN 4.2M
- IPO Year
- KZIA 1999
- APDN N/A
- Fundamental
- Price
- KZIA $3.80
- APDN $0.34
- Analyst Decision
- KZIA Strong Buy
- APDN Strong Buy
- Analyst Count
- KZIA 2
- APDN 1
- Target Price
- KZIA $57.50
- APDN $75.00
- AVG Volume (30 Days)
- KZIA 20.6K
- APDN 1.2M
- Earning Date
- KZIA 06-10-2025
- APDN 05-15-2025
- Dividend Yield
- KZIA N/A
- APDN N/A
- EPS Growth
- KZIA N/A
- APDN N/A
- EPS
- KZIA N/A
- APDN N/A
- Revenue
- KZIA $1,655,324.00
- APDN $3,790,616.00
- Revenue This Year
- KZIA N/A
- APDN $57.08
- Revenue Next Year
- KZIA N/A
- APDN $40.00
- P/E Ratio
- KZIA N/A
- APDN $0.07
- Revenue Growth
- KZIA 248000.00
- APDN N/A
- 52 Week Low
- KZIA $2.86
- APDN $0.29
- 52 Week High
- KZIA $79.00
- APDN $177.00
- Technical
- Relative Strength Index (RSI)
- KZIA 54.11
- APDN 15.59
- Support Level
- KZIA $3.24
- APDN $0.50
- Resistance Level
- KZIA $3.75
- APDN $0.62
- Average True Range (ATR)
- KZIA 0.28
- APDN 0.07
- MACD
- KZIA 0.05
- APDN 0.02
- Stochastic Oscillator
- KZIA 74.60
- APDN 8.34
About KZIA Kazia Therapeutics Limited
Kazia Therapeutics Ltd is an oncology-focused biotechnology company, developing anti-cancer drugs. The group is developing paxalisib, a potential treatment for glioblastoma; Cantrixil, being developed for the treatment of ovarian cancer; and Others. The company is also developing EVT801 for the treatment of various tumors. Maximum of revenue is earned from South Korea.
About APDN Applied DNA Sciences Inc.
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.